GM21501
Fibroblast from Skin, Unspecified
Description:
EHLERS-DANLOS SYNDROME: TYPE IV; ARTERIAL, ECCHYMOTIC TYPE
COLLAGEN, TYPE III, ALPHA-1; COL3A1
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases |
Biopsy Source
|
Unspecified
|
Cell Type
|
Fibroblast
|
Tissue Type
|
Skin
|
Transformant
|
Untransformed
|
Sample Source
|
Fibroblast from Skin, Unspecified
|
Family Member
|
1
|
Relation to Proband
|
proband
|
Confirmation
|
Molecular characterization before cell line submission to CCR
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
PDL at Freeze |
4.5 |
Passage Frozen |
6 |
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin confirmed by LINE assay |
|
Gene |
COL3A1 |
Chromosomal Location |
2q31 |
Allelic Variant 1 |
skipped exon 16; EHLERS-DANLOS SYNDROME,TYPE IV |
Identified Mutation |
IVS15-2A>G |
Remarks |
Clinically affected; severe skin findings; pain in left knee and right heel; osteoporosis; blue sclerae; quiet bowel sound; carotid bruit left; varicosities; blood pressure 116/64; poor wound healing; bruising; piezogenic papules; mild hyperextension and osteopenia in hips; joint limitations; mild disc herniation at C2-C3 and C3-C4; dural ectasia at L5-S1; anterolisthesis; L4-L5 disc buldge; donor subject has an A>G transversion in the 3' acceptor site of intron 15 of the COL3A1 gene [IVS15-2A>G] resulting in the skipping of exon 16; see GM21500 Lymphoid |
Gene Cards |
COL3A1 |
Gene Ontology |
GO:0005201 extracellular matrix structural constituent |
|
GO:0005581 collagen |
|
GO:0005586 collagen type III |
|
GO:0005737 cytoplasm |
|
GO:0006817 phosphate transport |
|
GO:0008015 circulation |
|
GO:0009887 organogenesis |
NCBI Gene |
Gene ID:1281 |
NCBI GTR |
120180 COLLAGEN, TYPE III, ALPHA-1; COL3A1 |
|
130050 EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC |
OMIM |
120180 COLLAGEN, TYPE III, ALPHA-1; COL3A1 |
|
130050 EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC |
Omim Description |
EDS IV |
|
EDS4 |
|
EHLERS-DANLOS SYNDROME, ARTERIAL TYPE |
|
EHLERS-DANLOS SYNDROME, ECCHYMOTIC TYPE |
|
EHLERS-DANLOS SYNDROME, SACK-BARABAS TYPE |
|
EHLERS-DANLOS SYNDROME, TYPE IV, AUTOSOMAL DOMINANT |
Cumulative PDL at Freeze |
10.3 |
Passage Frozen |
6 |
Split Ratio |
1:3 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
AMBIENT |
Medium |
Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not inactivated |
Substrate |
None specified |
Supplement |
- |
|
|